Shares of domain name registry operator Verisign (NASDAQ:VRSN) fell 8.5% in the morning session after news that major ...

Since first buying in 2012, Berkshire had built a 13.29 million?share position worth $4.07 billion before this sale, turning ...

Berkshire Hathaway ( NYSE: BRK.A) ( NYSE: BRK.B) sold about one-third of its stake in VeriSign ( NASDAQ: VRSN )—an internet ...

VeriSign shares fell on Tuesday after Warren Buffett's Berkshire Hathaway sold nearly one-third of its stake in the internet ...

VeriSign Inc. shares drop as Berkshire Hathaway sells chunk of holdings. Sale aims to reduce ownership below 10% regulatory ...

Berkshire Hathaway sold about one-third of its stake in VeriSign , an internet infrastructure and domain name registry ...

VeriSign (VRSN) was trading higher despite mixed second-quarter results as the internet infrastructure and domain name ...

(NASDAQ: VRSN) (the “Company”), a global provider of critical internet infrastructure and domain name registry services, today announced the pricing of the previously announced underwritten secondary ...

(NASDAQ: VRSN) (the “Company”), a global provider of critical internet infrastructure and domain name registry services, today announced the launch of an underwritten secondary offering (the “Offering ...

Famed investor Warren Buffett is booking profits and selling down his stake in internet domain registry Verisign (VRSN).

VeriSign, Inc. (NASDAQ:VRSN) saw its stock fall 6.5% in pre-market trading following Berkshire Hathaway’s announcement of a secondary offering of 4.3 million VeriSign shares priced at $285.00 each.

The biotechnology market experiences significant growth, fueled by advancements in genetic therapies and supportive global regulations. Considering the advancements, fundamentally solid biotech stocks ...